Prognostic Value of Tumor Heterogeneity on 18f-FDG PET/CT in HR+HER2− Metastatic Breast Cancer Patients Receiving 500 Mg Fulvestrant: A Retrospective Study

Scientific Reports - United Kingdom
doi 10.1038/s41598-018-32745-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search